Utama › Dermatitis Atopik (Eksim) › Alabama › Birmingham
Kajian klinikal Dermatitis Atopik (Eksim) di Birmingham, AL
9 kajian untuk Dermatitis Atopik (Eksim) sedang mencari peserta di lokasi dalam dan sekitar Birmingham (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Mengambil pesertaKajian pemerhatian
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006, Birmingham
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- Enveda Investigative Site, Birmingham
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Mengambil pesertaFasa 3
- Cahaba Dermatology & Skin Health Center, Birmingham
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Mengambil pesertaFasa 3
- Leo Pharma Investigational site, Birmingham
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Mengambil pesertaFasa 3
- Cahaba Dermatology & Skin Health Center /ID# 263855, Birmingham
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- Allervie Clinical Research, Birmingham
Kajian Dermatitis Atopik (Eksim) di bandar lain
- New York City, NY13 kajian
- Washington, DC11 kajian
- Los Angeles, CA11 kajian
- San Diego, CA10 kajian
- San Antonio, TX10 kajian
- Miami, FL9 kajian
- Troy, MI8 kajian
- Huntington Beach, CA8 kajian
- Dallas, TX8 kajian
- Sacramento, CA8 kajian
- Tampa, FL7 kajian
- Indianapolis, IN7 kajian
Kajian lain di Birmingham
- Kanser (semua jenis)30 kajian
- Kanser Payudara24 kajian
- Obesiti23 kajian
- Kanser Ovari23 kajian
- Kanser Paru-paru Bukan Sel Kecil22 kajian
- Leukemia Mieloid Akut21 kajian
- Mieloma Pelbagai18 kajian
- COPD17 kajian
- Penyakit Kardiovaskular17 kajian
- Berat Badan Berlebihan16 kajian
- Kanser Endometrium16 kajian
- Diabetes Jenis 216 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.